The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

October marks Breast Cancer Awareness Month. Here's how many Ohioans are diagnosed in 2025, and how to get a free screening.

ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in mUCCRB-701 continues to demonstrate a favorable safety and ...

"It wasn’t until I developed a random blind spot in my eye that my mom took me to the ER. They ordered a head CT that caught ...

Cancer is a life threatening condition, and its early diagnosis and prevention are the only two things that matter before it ...

Numerous studies have demonstrated a strong link between the human microbiome and the progression of various diseases, including obesity, diabetes ...

First DNA Cancer Vaccine Commercial Approval Expected By 2030 Says Kuick ResearchDelhi, Oct. 16, 2025 (GLOBE NEWSWIRE) -- ...

Camrelizumab plus famitinib significantly improved PFS and OS compared to platinum-based chemotherapy in recurrent/metastatic cervical cancer. The trial reported a median PFS of 11.1 months for the ...

Obstetrician-Gynaecologist, Professor Samuel Antwi Oppong, has explained that while ovarian cancer is one of the most ...

Investing.com -- Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) stock jumped 9.5% in Monday premarket trading after the company reported promising efficacy data for its cancer treatment CRB-701 in ...